Cencora, Inc.’s $1.8 Billion Registered Senior Notes Offering
December 23, 2024
Cravath represented the underwriters in connection with the $1.8 billion registered senior notes offering of Cencora, Inc., a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. The transaction closed on December 9, 2024.
The Cravath team included partners D. Scott Bennett and Ryan J. Patrone and associates Katie DelGhingaro and Ali Jimenez on capital markets matters; partner Arvind Ravichandran and associates Sonia Katharani‑Khan and Ruth Goldstein Schapiro on tax matters; and partner Matthew Morreale, senior attorney Annmarie M. Terraciano and associate Star S. Gulant on environmental matters. Catherine M. Crevecoeur also worked on capital markets matters.
Related Practices & Industries
People
- Photo
-
-
J.D., 2006, Emory University School of Law
-
B.A., 2002, Duke University
- New York
Education
Admitted In
- Photo
-
-
J.D., 2015, New York University School of LawOrder of the Coif; Florence Allen Scholar, magna cum laude
-
B.S., 2012, University of Floridasumma cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 2012, Columbia Law School
-
B.A., 2009, Columbia College
- New York
Education
Admitted In
- Photo
-
-
J.D., 1997, Columbia Law SchoolHarlan Fiske Stone Scholar
-
M.S., 1994, University of Pennsylvania
-
B.A., 1990, University of Pennsylvania
-
B.A.S., 1990, University of Pennsylvania
- New York
Education
Admitted In
- Photo
-
-
J.D., 1998, Columbia Law SchoolHarlan Fiske Stone Scholar
-
M.S., 1994, University of Wisconsin - Madison
-
B.A., 1989, Wellesley Collegecum laude
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
June 18, 2025
Cencora, Inc.’s $4.5 Billion Revolving Credit Facility
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with a $4.5 billion revolving credit facility made available to Cencora, Inc., a leading global pharmaceutical sourcing and distribution services company, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The transaction closed on June 4, 2025.
Deals & Cases
June 05, 2025
Cencora, Inc.’s €1 Billion Registered Senior Notes Offering
Cravath represented the underwriters in connection with the €1 billion registered senior notes offering of Cencora, Inc., a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. The transaction closed on May 22, 2025.
Deals & Cases
February 22, 2024
Cencora, Inc.’s Registered Senior Notes Offering
Cravath represented the underwriters in connection with the $500 million registered senior notes offering of Cencora, Inc., a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. The transaction closed on February 7, 2024.
